This Week in the Medical Journals GenomeWeb Also in Lancet Oncology, a second team of MD Anderson researchers collaborated with researchers from New Jersey and Puerto Rico in a trial of rituximab combined with lenalidomide to treat relapsed or refractory mantle-cell lymphoma. In phase one of the ... |
